| 25.41 |  +0.36 / +1.44% |
Data as of 3:59pm ET | Day’s Change |
| 25.41 |  0.00 / 0.00% |
Volume: 18.9K |
| Previous close | 25.05 |
| Today’s open | 25.10 |
| Day’s range | 25.00 - 25.63 |
| Volume | 157,398 |
| Average volume (3 months) | 189,476 |
| Market cap | $845.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -34.78% |
| Earnings growth (this year) | +148.89% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | -1.80% |
| P/E ratio | 49.8 |
| Price/Sales | 3.96 |
| Price/Book | 4.19 |
| Today’s change | Today’s % change | |
|---|---|---|
| VIVOMeridian Bioscience ... | +0.22 | +1.02% |
| GHDXGenomic Health Inc | +1.08 | +3.28% |
| DNDNDendreon Corp | -0.02 | -0.49% |
| AMAGAMAG Pharmaceuticals... | +0.52 | +2.57% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $155.7M |
| Annual profit (last year) | $5.0M |
| Net profit margin | 3.21% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Douglas C. Bryant |
Senior Vice President- Operations Scot M. McLeod |
Corporate headquarters San Diego, California |
.
